ERA accurately determines fertility status of mother, best time for embryo transfer.
Couples undergoing IVF can now rejoice as a new revolutionary technology can increase the chances of pregnancy in patients with repeated implantation failure. Endometrial Receptivity Array (ERA) a patented technology, introduced for the first time in Mumbai by Iviomics, a pioneer in reproductive genetic services, can precisely determine the optimum time for implantation of the embryo in the mother.
The test which is a result of over 10 years of research and 3,000 clinical trials determines how receptive a woman’s uterus (endometrial receptivity) is at a particular stage in her menstrual cycle by analyzing the fertility factor of 238 genes rather than merely relying on the structure and appearance of the endometrium.
IVF clinicians who are using the technology say the test is revolutionary in many aspects as it is highly sensitive and accurate.
